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Background: Few studies have examined if maternal allergic disease is associated with
an offspring’s neurodevelopment. We hypothesized that Th-2 biased maternal immune
function assessed as total serum immunoglobulin (Ig) E is associated with attention deficit
hyperactivity disorder (ADHD).
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Methods: Data are from the Wayne County Health, Environment, Allergy, and Asthma
Longitudinal Study (WHEALS), a racially and socioeconomically diverse birth cohort
in metropolitan Detroit, Michigan. Maternal total IgE was measured prenatally and at
1-month postpartum. Child total IgE was assessed at birth, 6 months, and 2 years
of age. ADHD diagnosis was based on the parental report at the 10–12-year study
visits or medical chart abstraction. Total IgE was log2 transformed. Poisson regression
models with robust error variance were used to calculate the risk ratios (RR). Inverse
probability weighting was used to correct for potential bias due to a loss to follow-up
and non-response.
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Results: Of the 636 maternal-child pairs in the analysis, 513 children were neurotypical
and 123 had ADHD. Maternal prenatal total IgE was significantly associated with ADHD
even after adjustment for potential confounders (RR = 1.08, 95% CI 1.03–1.13). Maternal
and child IgE measures were positively and significantly correlated, but child total IgE was
not associated with ADHD at any time point.
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Conclusions: Maternal prenatal IgE may influence neurodevelopment, but additional
studies are needed to confirm and expand these findings.
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INTRODUCTION
Neurodevelopmental disorders, such as autism spectrum disorder (ASD) and attention deficit
hyperactivity disorder (ADHD), have risen in prevalence over the last 15–20 years. Current
estimates suggest that one in 59 children are affected with ASD and 9% of children are affected with
ADHD (1–3). Interestingly, increases in the prevalence of atopic disease, such as allergy and asthma,
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postpartum, and interviewer-administered questionnaires were
completed at child age one, six, 12, and 24 months. Children and
their parent/guardian were invited to return for a clinic visit at
child age of 2 years and again at child age of 10–12 years for
assessment of child health. All participants provided a written,
informed consent and study protocols were approved by the
Henry Ford Health System Institutional Review Board; at the age
10–12 year visit, children provided a written, informed assent.
Of the 1,258 maternal-child pairs in the WHEALS cohort,
1,201 had a maternal total IgE measurement at either the prenatal
visit or 1-month postpartum visit. Of those, 651 maternal-child
pairs were followed through 10 years of age and had information
on neurodevelopmental outcomes. Seven children with a sensory
processing disorder, but not ADHD, and eight children with ASD,
but not ADHD, were removed prior to the analysis, leaving a total
of 636 maternal-child pairs in the final analytic sample.

have also occurred during the same time period (4–6). Several
authors have noted these concurrent trends as well as the high
comorbidity of ASD/ADHD and atopic disease (7–11). However,
evidence suggesting an association between neurodevelopmental
disorders and atopic disease is inconsistent and stems largely
from retrospective or cross-sectional studies (7–9, 11, 12).
There are important interactions between the immune and
neural systems throughout life beginning in the prenatal period
(13, 14). A growing body of research suggests that both atopic
disease and neurodevelopmental disorders such as ADHD have
their origins, at least in part, in utero (15, 16). Thus, it is
possible that atopic disease and ADHD, two seemingly diverse
outcomes, are both associated with early-life exposures that
alter the immune environment during prenatal life. In support
of this possibility, maternal prenatal allergy and asthma has
emerged as a risk factor for both ASD and other developmental
disorders in the offspring (17). In one Australian study of 420
healthy term infants, children born to mothers with a history
of allergic disease were more likely to have an allergic disease
and suboptimal neurodevelopmental outcomes at 12–18 months
of age (18). Total serum concentrations of immunoglobulin (Ig)
E are strongly but imperfectly associated with the presence of
allergic diseases (19, 20). Maternal IgE levels during pregnancy
are associated with a risk of atopic disease in the offspring,
perhaps as a surrogate marker of the relative balance of maternal
Th-1 and Th-2 immunity (20–22). However, maternal immune
function and maternal factors associated with offspring atopy
(i.e., IgE) have not been thoroughly examined in relation to
ADHD. Investigating the possible relationships between the
levels of IgE during critical windows of offspring development
and before the onset of ADHD symptoms may offer important
insights into the etiologies of this disorder.
Consequently, we hypothesize that ADHD is associated with
an early life immune function or sensitization that does not
necessarily result in an overt atopic disease, as measured by
maternal prenatal total IgE in the prenatal and perinatal periods.
The association between offspring early life and childhood
total IgE through age two and ADHD are also examined.
These analyses were conducted in a large prospective and
racially/socioeconomically diverse birth cohort study from the
Detroit metropolitan area in southeastern Michigan.

Total IgE Measurement
Blood was collected from mothers during the prenatal visit and
at the 1-month postpartum home visit, while blood was collected
from children at birth (umbilical cord blood), 6-months, 1year, and 2-years. Total IgE (IU/mL) was measured in all blood
samples with the Pharmacia UniCAP system (Phadia, Portage,
MI) using the manufacturer’s standard protocols. Further
details on the total IgE measurement have been previously
published (23).

Definition of ADHD and Neurotypical
Development
At the age 10–12-year visit, the caregiver (95% the mother)
reported if the child had ever been diagnosed with ADHD,
ASD, Asperger’s syndrome, or a sensory processing disorder. A
question about Asperger’s syndrome was asked separately since
children may have been diagnosed prior to the Diagnostic and
Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
Caregiver report of a “suspect” diagnosis was also classified as
positive for the primary analysis.
A subset of 325 WHEALS children who had received care
from the Henry Ford Health System providers had their medical
records abstracted for additional health information, including
ADHD diagnoses. Caregiver report of ADHD diagnosis was
validated within this subset using the kappa (κ) statistic to
evaluate agreement. Landis and Koch (25) criteria were used to
evaluate strength of agreement. As previously reported, there was
a high degree of agreement between caregiver-reported ADHD
and the medical record (κ = 0.84, 95% CI 0.78–0.91) (26). Given
that only a subset of children had a medical record review and
moderate to high level of agreement between caregiver report
and the medical record, the statistical analysis classified a child
as having ADHD if their caregiver-reported ADHD or if it was
reported in the medical record.
Children with ADHD were compared to children who
were considered neurotypical (NT) because they did not
have a caregiver-reported neurodevelopmental diagnosis. Other
neurodevelopmental disorders were not evaluated as a separate
outcome due to the small sample sizes. To evaluate the robustness
of the results, two sensitivity analyses were performed in addition

MATERIALS AND METHODS
Study Population
The Wayne County Health, Environment, Allergy, and Asthma
Longitudinal Study (WHEALS) recruited pregnant women with
due dates from September 2003 through December 2007, and
who were seeing a practitioner at one of five clinics in the
Henry Ford Health System to establish a birth cohort (23,
24). All women were in their second trimester or later, aged
21–49 years, and living in a predefined geographic area in
Wayne and Oakland counties that included the city of Detroit
as well as the suburban areas immediately surrounding the
city. Mothers were interviewed in the clinic prenatally and
Abbreviations: Ig, immunoglobulin; Pre, prenatal; M, month; Y, Year.
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before and after weighting, with imbalance defined as absolute
value >0.20.
To evaluate the association between maternal total IgE
(prenatal and at 1 month postpartum) and ADHD in offspring,
risk ratios (RR) were obtained from Poisson regression models
using a robust error variance (30). In all the models, subjects
were weighted using the IPW described previously. Models
were evaluated both before and after adjusting for potential
confounders. Potential confounders were selected as those
that were significantly associated with maternal total IgE
and ADHD and included maternal age at birth, household
income, marital status, maternal education, maternal prenatal
smoking, household prenatal smoke exposure, prenatal pet
exposure, maternal prenatal BMI, prenatal antibiotic use,
prenatal antifungal use, first born child, mode of delivery,
gestational age at birth, birthweight z-score, child sex, child race,
and breastfeeding status at 1-month. From this pre-specified set
of hypothesized confounders, child sex and prenatal antifungal
use met these criteria. Child sex and breastfeeding status at 1month were a priori specified as potential effect modifiers and
were tested using multiplicative interaction terms.
Because there was covariate missingness in the analytic
dataset, multiple imputation was performed in addition to a
complete-case analysis. A total of 20 imputed datasets were
calculated using all exposure variables, the outcome of interest,
confounders, and the IPW for loss to follow-up. The SAS
procedure MI (SAS Institute Inc., Cary, NC) with the fully
conditional specification algorithm was used to generate imputed
datasets; imputation quality was assessed via trace plots and
variance information (31). The SAS mianalyze procedure was
used to pool estimates.

to the primary analysis of all ADHD cases relative to NT: (1)
ADHD cases with a “suspect” parental diagnosis but no chart
abstracted diagnosis were removed, and (2) ADHD cases with
a comorbid ASD diagnosis (defined via parental report or chart
abstraction) were removed.

Covariates
Maternal self-reported race, date of birth, marital status,
household income, address, education, insurance type, parity,
alcohol use, pet keeping, allergic disease, smoking history, and
exposure to environmental tobacco smoke (ETS) were collected
at the prenatal interview. Maternal prenatal care records were
abstracted to obtain prescription antibiotic and antifungal use
(27). Height and weight were also abstracted and body mass index
(BMI; kg/m2 ) at the first prenatal care visit (mean gestational
age measure at 9.1 ± 4.9 weeks; 83% were taken during the first
trimester) were calculated. Although the first measured BMI in
pregnancy and self-reported prepregnancy BMI have been shown
to be highly correlated in other studies (28), the first measured
BMI during pregnancy represents both prepregnancy body size
and early pregnancy-related weight gain. Delivery records for
WHEALS women were abstracted to obtain delivery mode, birth
weight, and gestational age at delivery.

Statistical Analysis
In order to describe the differences in children included and
excluded from the analyses and to describe differences by ADHD
status, analysis of variance was used for continuous covariates
while chi-square tests were used for categorical covariates (unless
any cell sizes were <5, in which case, the Fisher’s exact test
was used). For descriptive purposes, total IgE measurements
were first compared on the untransformed IU/mL scale, with
between group differences evaluated using the Wilcoxon rank
sum test. In order to have meaningful coefficients in regression
models (described further in the Results), total IgE measurements
were log2-transformed prior to model inclusion. The log2
transformation was also used to examine Pearson correlations
between total IgE measurements in order to meet normality
assumptions. Supplementary Figure 1 demonstrates that both
log2 and natural log transformation of the IgE values effectively
normalized them. Because a loss to follow-up and non-response
can affect the internal validity of estimates, inverse probability
weighting (IPW) was used to correct for this bias (29). Analytic
sample inclusion was used as the outcome in a logistic regression
model with the following covariates: maternal age at delivery,
maternal race, insurance type, household income, marital status,
maternal education, location of residence (urban vs. suburban),
maternal prenatal smoking, prenatal ETS, prenatal alcohol use,
prenatal indoor pets, maternal allergic disease (allergies and
asthma), mode of delivery, parity, child sex, gestational age at
birth, and birth weight. The predicted probability of inclusion
for each subject was extracted from this model; weights were
calculated as the inverse of the “treatment” received. In other
words, if p = probability of inclusion, then IPW = 1/p for
included children and IPW = 1/(1-p) for excluded children.
Covariate balance was assessed using the standardized differences
(difference in means or proportions divided by standard error)

Frontiers in Pediatrics | www.frontiersin.org

RESULTS
Among the 636 maternal-child pairs included in the analysis,
123 (19.1%) were diagnosed with ADHD and 513 (79.7%) were
NT. Ten children had both ADHD and ASD. The comparison
of children included and excluded from analyses are shown in
Table 1. Children included in the analysis were more likely to
have mothers with Health Alliance Plan coverage (an insurance
company owned by the Henry Ford Health System), higher
household incomes, at least a bachelor’s degree, and were more
likely to be married and live in a suburban residence (all p
< 0.05). Included mothers were also older on average and
less likely to smoke or be exposed to tobacco smoke during
pregnancy; included children on average also weighed more at
birth. Standardized differences of these associations were as large
as 0.75; however, after weighting the subjects by their IPW for
loss to follow-up, no significant associations were found, and
the absolute value of all standardized differences were <0.20
(maximum = 0.04), which suggested that balance was achieved
in these covariates between the included and excluded subjects
after weighting.
The association between maternal and child characteristics
and ADHD was also examined (Table 2). Maternal prenatal BMI,
maternal report of doctor diagnosed hay fever or allergic rhinitis,
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TABLE 1 | Description of maternal-child pairs included and excluded from the analysis.
Covariate

Level

Excluded
N = 622

Included
N = 636

N (Column %) or N, Mean ± SD
Race-ethnicity of mother

Caucasian
African American

Mother married
Maternal education

384 (60.4%)

38 (6.1%)

40 (6.3%)

Arabic

30 (4.8%)

29 (4.6%)

23 (3.7%)

30 (4.7%)

Health Alliance Plan

172 (27.7%)

330 (51.9%)

Other insurance

198 (31.8%)

233 (36.6%)

No insurance
Household income

153 (24.1%)

Hispanic
Other/Mixed
Insurance coverage

137 (22%)
394 (63.3%)

9 (1.4%)

6 (0.9%)

Refused/do not know/missing

243 (39.1%)

67 (10.5%)

<$20,000

116 (18.6%)

66 (10.4%)

$20,000–$40,000

147 (23.6%)

148 (23.3%)

$40,000–$80,000

175 (28.1%)

172 (27%)

$80,000–$100,000

49 (7.9%)

86 (13.5%)

≥$100,000

59 (9.5%)

89 (14%)

Refused to answer

76 (12.2%)

75 (11.8%)

No

270 (43.4%)

215 (33.8%)

Yes

352 (56.6%)

421 (66.2%)

<High school diploma

0.041

<0.001

0.751

0.99

0.001

<0.001

0.338

0.99

0.036

<0.001

0.198

0.51

0.026

<0.001

0.352

0.97

0.030

312 (50.2%)

293 (46.1%)

127 (20.4%)

224 (35.2%)

622, 29.1 ± 5.2

636, 30.0 ± 5.2

0.001

0.185

0.90

0.005

0.020

−0.131

0.84

−0.008

<0.001

−0.215

0.52

0.026

0.002

−0.174

0.72

0.014

0.95

0.004

0.81

−0.009

0.091

0.095

0.85

−0.008

0.33

0.055

0.42

0.032

0.75

0.013

0.93

0.001

0.92

0.005

0.87

−0.007

0.97

0.003

0.74

0.015

0.031

0.122

0.96

0.002

0.80

−0.016

0.58

0.021

Urban

368 (59.2%)

335 (52.7%)

526 (84.6%)

582 (91.5%)

Yes

96 (15.4%)

54 (8.5%)

No

426 (68.5%)

485 (76.3%)

Yes

196 (31.5%)

151 (23.7%)

No

596 (96.1%)

610 (96.1%)

Yes

24 (3.9%)

25 (3.9%)

No

485 (78%)

470 (73.9%)

Yes

137 (22%)

166 (26.1%)

No

528 (84.9%)

527 (82.9%)

Yes

94 (15.1%)

109 (17.1%)

Maternal doctor diagnosed hay fever or allergic rhinitis No

526 (85.3%)

528 (84.6%)

Yes

91 (14.7%)

96 (15.4%)

No

498 (80.1%)

507 (79.8%)

Yes

124 (19.9%)

128 (20.2%)

Child sex

0.98

≥Bachelor’s degree

No

First born child

0.074

Some college

Mom smoked during pregnancy

Mode of delivery

0.76

23 (3.6%)

301 (47.3%)

Maternal doctor diagnosed asthma

Dc

96 (15.1%)

254 (40.8%)

Prenatal indoor cats

p-valueb

51 (8.2%)

Suburban

Prenatal indoor dogs

Dc

132 (21.2%)

Location of residence

Prenatal alcohol use

p-valueb

After IPWa

High school diploma

Maternal age at birth (years)

Prenatal ETS exposure

Before IPWa

Vaginal

386 (62.7%)

398 (62.8%)

C-section

230 (37.3%)

236 (37.2%)

No

413 (66.4%)

385 (60.5%)

Yes

209 (33.6%)

251 (39.5%)

Male

305 (49.1%)

317 (49.8%)

Female

316 (50.9%)

319 (50.2%)

Gestational age at delivery (weeks)
Birth weight (grams)

604, 38.7 ± 1.8

628, 38.7 ± 1.7

0.56

0.030

0.95

−0.004

576, 3,259 ± 556

606, 3,347 ± 587

0.009

0.148

0.91

−0.005

ETS, environmental tobacco smoke; SD, standard deviation.
a Inverse probability weighting (IPW) to account for loss to follow-up.
b Calculated by analysis of variance for numerical covariates and chi-square test for categorical covariates.
c Standardized difference, defined as the difference in means or proportions divided by standard error.
The bold values indicate statistical significance.
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TABLE 2 | Maternal and child characteristics associated with ADHD (N = 636).
Covariate

Level

ADHDa
N = 123

NT
N = 513

p-value

N (Column %) or N, Mean ± SD
Household income

Mother married
Maternal education

50 (9.7%)

16 (13%)

$20,000–$40,000

113 (22%)

35 (28.5%)

$40,000–$80,000

138 (26.9%)

34 (27.6%)

$80,000–$100,000

72 (14%)

14 (11.4%)

<$20,000

≥$100,000

79 (15.4%)

10 (8.1%)

Refused to answer

61 (11.9%)

14 (11.4%)

No

169 (32.9%)

46 (37.4%)

Yes

344 (67.1%)

77 (62.6%)

0.21b

0.35b
0.067c

<High school diploma

20 (3.9%)

3 (2.4%)

High school diploma

76 (14.8%)

20 (16.3%)

Some college

225 (43.9%)

68 (55.3%)

≥Bachelor’s degree

192 (37.4%)

32 (26%)

Maternal age at birth (years)

513, 30.2 ± 5.2

123, 29.6 ± 5.3

0.26d

Maternal BMI-first measured in pregnancy

487, 30.2 ± 7.5

109, 32.5 ± 9.1

0.004d

471 (91.8%)

111 (90.2%)

0.58b

Mom smoked during pregnancy
Prenatal ETS exposure
Prenatal indoor pets
Prenatal antibiotic use
Prenatal antifungal use
Child sex
Race-ethnicity of child

First born child
Mode of delivery

No
Yes

42 (8.2%)

12 (9.8%)

No

397 (77.4%)

88 (71.5%)

Yes

116 (22.6%)

35 (28.5%)

No

327 (63.7%)

72 (58.5%)

Yes

186 (36.3%)

51 (41.5%)

No

204 (46.6%)

46 (44.2%)

Yes

234 (53.4%)

58 (55.8%)

No

366 (83.6%)

72 (69.2%)

Yes

72 (16.4%)

32 (30.8%)

Male

227 (44.2%)

90 (73.2%)

Female

286 (55.8%)

33 (26.8%)

White

110 (21.4%)

28 (22.8%)

African American

310 (60.4%)

79 (64.2%)

Other/Mixed

93 (18.1%)

16 (13%)

No

319 (62.2%)

66 (53.7%)

Yes

194 (37.8%)

57 (46.3%)

Vaginal

324 (63.3%)

74 (60.7%)

C-section

Maternal doctor diagnosed asthma

0.67b
<0.001b
<0.001b
0.40b

0.082b
0.59b

188 (36.7%)

48 (39.3%)
120, 38.3 ± 2.0

0.003d

490, −0.04 ± 1.0

111, −0.04 ± 0.99

0.96d

Not breastfed

101 (20.3%)

24 (20.5%)

0.95b

Mixed feeding

323 (64.9%)

77 (65.8%)

Birthweight z-score

Maternal doctor diagnosed hay fever or allergic rhinitis

0.28b

508, 38.8 ± 1.6

Gestational age at delivery (weeks)
Breastfeeding status at 1-month

0.17b

Breastfeeding only

74 (14.9%)

16 (13.7%)

No

438 (86.2%)

90 (77.6%)

Yes

70 (13.8%)

26 (22.4%)

No

418 (81.6%)

89 (72.4%)

Yes
Mother prenatal total IgE (IU/mL)
Mother 1-month total IgE (IU/mL)

0.020b
0.021b

94 (18.4%)

34 (27.6%)

385, 33.7 ± 4.1e

99, 49.2 ± 4.4e

489, 36.7 ± 4.4

e

116, 52.9 ± 4.9

e

0.005f
0.005f

ADHD, attention deficit hyperactivity disorder; BMI, body mass index; ETS, environmental tobacco smoke; Ig, immunoglobulin; NT, neurotypical; SD, standard deviation.
a includes 10 children with both ADHD and ASD.
b Calculated by the chi-square test.
c Calculated by Fisher’s exact test (at least one cell size <5).
d Calculated by analysis of variance.
e Geometric mean and standard deviation.
f Calculated by the Wilcoxon rank sum test.
The bold values indicate statistical significance.
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TABLE 3 | Association between the maternal total IgE measurements and ADHD in the offspring.
Model 1a

Exposure

Model 2b

Model 3c

N

RR (95% CI)d

p-value

N

RR (95% CI)d

p-value

N

RR (95% CI)d

p-value

Mother prenatal total IgE

484

1.10 (1.05, 1.15)

<0.001

404

1.07 (1.01, 1.12)

0.014

636

1.08 (1.03, 1.13)

0.001

Mother 1-month total IgE

605

1.08 (1.04, 1.13)

<0.001

520

1.06 (1.01, 1.11)

0.025

636

1.03 (0.96, 1.10)

0.37

Mother prenatal total IgE

479

1.11 (1.06, 1.17)

<0.001

400

1.08 (1.02, 1.14)

0.007

629

1.09 (1.04, 1.14)

<0.001

Mother 1-month total IgE

599

1.10 (1.05, 1.15)

<0.001

515

1.07 (1.01, 1.12)

0.011

629

1.04 (0.97, 1.13)

0.30

Mother prenatal total IgE

479

1.10 (1.05, 1.15)

<0.001

400

1.08 (1.02, 1.14)

0.007

626

1.08 (1.03, 1.13)

<0.001

Mother 1-month total IgE

595

1.09 (1.04, 1.14)

<0.001

511

1.07 (1.02, 1.12)

0.009

626

1.03 (0.96, 1.11)

0.36

Full analysise

Sensitivity analysis #1f

Sensitivity analysis #2g

ADHD, attention deficit hyperactivity disorder; Ig, immunoglobulin; NT, neurotypical; RR, risk ratio.
a Inverse probability weights; unadjusted; complete-case analysis.
b Inverse probability weights; adjusted for child sex and prenatal antifungal use; complete-case analysis.
c Inverse probability weights; adjusted for child sex and prenatal antifungal use; multiple imputation analysis.
d Maternal total IgE measurements log2-transformed prior to analysis so that risk ratios are interpreted as the increase in risk of ADHD associated with a 2-fold increase in maternal
total IgE.
e All ADHD cases (N = 123) vs. NT (N = 513).
f ADHD cases with a “suspect” parental diagnosis have been removed (N = 7), leaving N = 116 ADHD cases vs. N = 513 NT for analysis.
g ADHD cases with a comorbid ASD diagnosis have been removed (N = 10), leaving N = 113 ADHD cases vs. N = 513 NT for analysis.
The bold values indicate statistical significance.

impacted and again remained statistically significantly associated
with ADHD (Model 3; RR 1.08, 95% CI 1.03–1.13, p < 0.001). In
both sensitivity analyses, there remained no association between
the 1-month postpartum IgE and ADHD. Additionally, child sex
and breastfeeding status at 1-month did not significantly modify
any of the associations between maternal IgE and ADHD (all
interaction p ≥ 0.20).
The correlations between maternal and child total IgE
measurements are shown in Figure 1. As expected, measures
were positively and significantly correlated, both within maternal
prenatal and postnatal time points (r = 0.91), within the
child at all time points (r minimum = 0.41, maximum =
0.86), and between mother and child at all time points (r
minimum = 0.14, maximum = 0.36). Consistent with what
we observed in Figure 1, all child total IgE measurements were
significantly positively associated with the maternal prenatal
total IgE, even after IPW and covariate adjustment (Table 4).
However, regardless of age at IgE assessment, child total IgE was
not significantly associated with ADHD in multivariable models
(Table 4). For example, for each 2-fold increase in child 2-year
total IgE, there was a 4% higher risk of ADHD, but this was not
significant (p = 0.38).

maternal doctor diagnosed asthma, prenatal antifungal use, child
sex, and gestational age at delivery all differed significantly
between children with ADHD relative to NT children (all p <
0.05). Specifically, relative to NT children, children with ADHD
had mothers with higher prenatal BMIs, were more likely to
use prenatal prescription antifungals and more likely to have a
self-reported history of hay fever or allergic rhinitis and asthma.
Children with ADHD were more likely to be male and on average
had earlier gestational ages at delivery. Of these characteristics,
only prenatal antifungal use and child sex were also significantly
associated with maternal total IgE (Supplementary Table 1).
Table 3 presents the associations between maternal total IgE
and ADHD. In the primary analysis including all 123 ADHD
cases, both measures of maternal total IgE were significantly
associated with ADHD prior to covariate adjustment (Table 3).
Specifically, for each 2-fold increase in the maternal prenatal total
IgE, the risk of ADHD increased by 10% (Model 1; RR 1.10, 95%
CI 1.05–1.15; p < 0.001); similarly, for each 2-fold increase in the
maternal 1-month total IgE, the risk of ADHD increased by 8%
(Model 1; RR 1.08, 95% CI 1.04–1.13; p < 0.001). After adjusting
for covariates in a complete-case analysis, both maternal prenatal
(Model 2; RR 1.07, 95% CI 1.01–1.12; p = 0.014) and 1-month
(Model 2; RR 1.06, 95% CI 1.01–1.11; p = 0.025) IgE remained
statistically significantly associated with ADHD. However, only
maternal prenatal IgE remained statistically significant in the
multiple imputation estimates (Model 3; RR 1.08, 95% CI 1.03–
1.13; p = 0.001). In the first sensitivity analysis removing seven
children who had a “suspect” ADHD diagnosis, results for the
maternal prenatal IgE were effectively unchanged (Model 3;
RR 1.09, 95% CI 1.04–1.14, p < 0.001). Results were again
consistent in the second sensitivity analysis where we repeated
the analysis after removing 10 children who had both ASD and
ADHD. Specifically, effect estimates with prenatal IgE were not
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DISCUSSION
The findings from this study suggest that maternal IgE during
pregnancy influences the risk of ADHD in an offspring.
Specifically, higher levels of maternal prenatal total IgE were
associated with a statistically significant increased risk of
ADHD diagnosis in the offspring, which remained after
covariate adjustment. Child IgE throughout the first 2 years
of life was not associated with ADHD. These findings are
significant because they highlight maternal prenatal total IgE
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FIGURE 1 | Correlation between the maternal and child total IgE measurements. Ig, immunoglobulin.

TABLE 4 | Associations between child total IgE and maternal prenatal total IgE and ADHD.
Child Total IgE Measurement

Association with Mother Prenatal Total IgE

Association with ADHD (vs NT)

β (95% CI)a

p-value

RR (95% CI)b

p-value

Cord

0.31 (0.22, 0.40)

<0.001

1.01 (0.94, 1.08)

0.85

6-months

0.14 (0.01, 0.28)

0.047

1.00 (0.88, 1.13)

0.98

1-year

0.26 (0.14, 0.39)

<0.001

1.01 (0.91, 1.13)

0.81

2-years

0.15 (0.04, 0.26)

0.006

1.04 (0.96, 1.12)

0.38

ADHD, attention deficit hyperactivity disorder; Ig, immunoglobulin; NT, neurotypical; RR, risk ratio.
a Interpreted as the mean increase in log2-transformed child total IgE, for a 1-unit increase in log2-transformed maternal prenatal total IgE, after adjusting for child sex and prenatal
antifungal use. Inverse probability weighting was used in all models.
b Change in outcome risk associated with a 2-fold increase in child total IgE, after adjusting for maternal prenatal total IgE, child sex, and prenatal antifungal use. Inverse probability
weighting was used in all models.
The bold values indicate statistical significance.

Furthermore, previous studies suggested that maternal IgE
is correlated with infant IgE (21, 34). In this analysis, we
found similar correlations, yet, in our study the infant total
IgE levels during early postnatal life were not associated with
ADHD. Other studies that have examined IgE in childhood
and neurodevelopment concurrently reported similar findings
(35, 36). Verlaet et al. found no association between the total IgE
and ADHD when IgE was measured in 6–12-year-old children
with and without ADHD (35). On the other hand, Wang et al.
found a positive association between the total IgE and ADHD
measured cross-sectionally in children 8–10 years of age (12). The
different age distributions in these studies may explain some of
the conflicting findings. Future studies should examine the rate
of change of IgE across infancy and childhood. Given the high

level as an important potential marker of risk of ADHD. To
our knowledge, few studies have examined prenatal exposure
to immunoglobulins generally and risk of ADHD or other
neurodevelopmental disorders such as ASD. While results of
other studies are not directly comparable to the findings
presented here, inferences may be drawn from similar work
on other neurodevelopmental outcomes. Grether et al. studied
maternal prenatal total IgG and total IgM and found no
association with the risk of ASD (32). However, IgE is
functionally distinct from IgG and IgM and results from
different types of immune responses. Higher levels of IgE are
associated with allergic disease and other responses (20, 33).
As such, different associations between ADHD or ASD and
immunoglobulin type are plausible.
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IgE changes differently during pregnancy in mothers with and
without sensitization and allergic symptoms, but that study was
small (N = 56) (44). In the WHEALS cohort, we previously
reported that the total IgE increased a small amount between
the prenatal and 1-month postpartum levels, but the change may
have been due to increases in the maternal blood volume during
pregnancy (45). Additional studies are needed to understand
whether maternal IgE changes during pregnancy and how it
could influence offspring neurodevelopment. In addition, future
studies should consider how the maternal prenatal use of
medications used to treat asthma and other allergic conditions
influence neurodevelopment.
In summary, we found that maternal prenatal total IgE, but
not early life or childhood levels of IgE, is associated with
an increased risk of ADHD. This finding suggests that the
prenatal period is an important window of exposure for risk of
ADHD and, as such, might be a critical time period in which
interventions to prevent these outcomes may be successful.

comorbidity between atopic disease and neurodevelopmental
diseases (7–11), it is somewhat surprising that in our data, there
is no association between IgE in early childhood and ADHD.
However, total IgE does not have an absolute association with any
form of overt allergic/asthmatic disease, so to some extent, this
might be expected (37). Furthermore, the prenatal period may be
the period where the developing brain is more vulnerable to the
maternal immune environment whereas IgE levels in childhood
are more representative of other disease processes or biologic
responses and exposures.
While this study does not specifically examine the
mechanisms by which IgE (or the immune functions marked
by IgE levels) may influence ADHD risk, we hypothesized that
fetal neurodevelopment is influenced by maternal prenatal
immune function. The concept of a link between the pattern
of maternal prenatal immune function and ASD or ADHD has
been discussed (14, 32, 38), yet as mentioned previously, studies
have not specifically examined the role of maternal prenatal
IgE in the development of ASD or ADHD in the offspring.
The placenta is the critical interface between the mother and
infant and IgE is not transported across the placenta as well
as IgG. However, IgE is present in the human placenta and
some studies have suggested that it may cross the placenta by
forming immune complexes with IgG (39–41). In one study
including 86 placentas, IgE was detected in all 86 placentas and
appeared to be bound to placental macrophages (40, 41). In
that study, the authors used a semiquantitative scoring system
and found that placentas from atopic mothers did not have
higher numbers of IgE cells (40). The histologic scoring system is
highly subjective; thus, measurement error remains a possibility.
Interestingly, placental macrophages are immunoprotective
(42) and high concentrations of placental macrophages may
be protective against ASD (16). The association with other
developmental disorders needs to be evaluated. It is possible
that there are differences in the prenatal exposure to IgE due to
differences in the concentration or distribution of the placental
macrophage as they bind IgE (40, 43). Additional studies
are needed to understand the importance of IgE sequestered
in the placenta and whether it enters fetal circulation, alters
placental function, or alters inflammatory and cytokine response
with neurodevelopment.
Our study has numerous strengths including a birth cohort
that is socioeconomically and racially diverse. In addition, the
cohort has a large number of prenatal biologic measures and data
related to atopic disease. Pregnant women were not recruited
based on disease history. Although we examined interactions
with child sex, given that ADHD affects a greater number of
males, this will be an important factor to further evaluate in
future studies. While measurement of prenatal exposures in
children who later develop ADHD are uncommon, it is also
important to note that this study only included two measures
of maternal total IgE (prenatal and 1 month postpartum), thus,
we are unable to assess the changes in the total IgE during
pregnancy. One previous study suggested that maternal total
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